Arvinas to Present Phase 1 Data for ARV-102, a PROTAC LRRK2 Degrader, in Oral Session at the 2026 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorder

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. ALAR
3. SPY
4. CCH:LN
5. META
6. BAJAJHFL:I
7. CCHGY
8. PRY:IM
9. PRYMY
10. EXC

Go back to Arvinas to Present Phase 1 Data for ARV-102, a PROTAC LRRK2 Degrader, in Oral Session at the 2026 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorder
(NASDAQ: ARVN) Delayed: 8.39 +0.19 (2.32%)
Previous Close $8.20    52 Week High $ 
Open $8.30    52 Week Low $ 
Day High $8.67    P/E N/A 
Day Low $8.16    EPS $ 
Volume 643,673       

(NASDAQ: ARVN) Delayed: 8.39 +0.19 (2.32%)
Previous Close $8.20    52 Week High $ 
Open $8.30    52 Week Low $ 
Day High $8.67    P/E N/A 
Day Low $8.16    EPS $ 
Volume 643,673